Indeed, calpain-mediated KCC2 loss is consistent with recent reports of reduced KCC2 levels in the chronic period following neonatal seizures (Puskarjov et al., 2015), and excess calpain activity in human epilepsy resections (Feng et al., 2011; Das et al., 2012). The gene discussed is SLC12A5; the disease is epilepsy.